Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 2 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer.
Oncogenesis. 2021 Feb 26;10(2):19. doi: 10.1038/s41389-021-00309-y.
Oncogenesis. 2021.
PMID: 33637673
Free PMC article.
Review.
Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profiles.
Ragusa D, Cicirò Y, Federico C, Saccone S, Bruno F, Saeedi R, Sisu C, Pina C, Sala A, Tosi S.
Ragusa D, et al. Among authors: ciciro y.
Oncogenesis. 2022 Sep 3;11(1):50. doi: 10.1038/s41389-022-00426-2.
Oncogenesis. 2022.
PMID: 36057683
Free PMC article.
Item in Clipboard
Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies.
Cicirò Y, Ragusa D, Sala A.
Cicirò Y, et al.
Sci Rep. 2024 Feb 23;14(1):4461. doi: 10.1038/s41598-024-55080-y.
Sci Rep. 2024.
PMID: 38396175
Free PMC article.
Item in Clipboard
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma.
Cicirò Y, Ragusa D, Nevado PT, Lattanzio R, Sala G, DesRochers T, Millard M, Andersson MK, Stenman G, Sala A.
Cicirò Y, et al.
FEBS Lett. 2024 Jan;598(2):252-265. doi: 10.1002/1873-3468.14786. Epub 2023 Dec 27.
FEBS Lett. 2024.
PMID: 38112379
Item in Clipboard
Cite
Cite